Finance
Results: 829-840 of 22882

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

Record 20th anniversary year results solidify DIFC's position as region's number one global financial centre
